The store will not work correctly when cookies are disabled.
N-[3,5-Dichloro-4-(3-isopropyl-1H-indol-5-yloxy)-phenyl]-oxalamic acid methyl ester
ID: ALA183122
PubChem CID: 44391411
Max Phase: Preclinical
Molecular Formula: C20H18Cl2N2O4
Molecular Weight: 421.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)C(=O)Nc1cc(Cl)c(Oc2ccc3[nH]cc(C(C)C)c3c2)c(Cl)c1
Standard InChI: InChI=1S/C20H18Cl2N2O4/c1-10(2)14-9-23-17-5-4-12(8-13(14)17)28-18-15(21)6-11(7-16(18)22)24-19(25)20(26)27-3/h4-10,23H,1-3H3,(H,24,25)
Standard InChI Key: CCTYHQGZHMQRSN-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
-3.3625 0.5833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2875 0.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5750 0.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8458 -0.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1792 -0.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3625 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3000 -0.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0000 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7375 -0.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4625 -0.9000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9000 -0.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5750 -0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7250 0.3458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0167 -0.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4208 0.7500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8625 0.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1458 0.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1625 0.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9000 -1.7167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6125 1.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8625 -0.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0000 1.5750 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.4208 -0.9042 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.1458 -0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6167 -0.4792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.4208 1.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0625 1.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3250 -0.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 15 1 0
3 1 1 0
4 1 2 0
5 10 1 0
6 4 1 0
7 2 2 0
8 2 1 0
9 13 1 0
10 9 1 0
11 5 1 0
12 3 2 0
13 8 2 0
14 7 1 0
15 17 1 0
16 3 1 0
17 16 2 0
18 5 2 0
19 11 2 0
20 1 1 0
21 12 1 0
22 8 1 0
23 7 1 0
24 17 1 0
25 11 1 0
26 20 1 0
27 20 1 0
28 25 1 0
6 12 1 0
24 21 2 0
9 14 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 421.28 | Molecular Weight (Monoisotopic): 420.0644 | AlogP: 5.50 | #Rotatable Bonds: 4 |
Polar Surface Area: 80.42 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.66 | CX Basic pKa: ┄ | CX LogP: 5.60 | CX LogD: 5.60 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.43 | Np Likeness Score: -0.68 |
References
1. Haning H, Woltering M, Mueller U, Schmidt G, Schmeck C, Voehringer V, Kretschmer A, Pernerstorfer J.. (2005) Novel heterocyclic thyromimetics., 15 (7): [PMID:15780617] [10.1016/j.bmcl.2005.02.028] |